Cardiovascular Disease / Hypertension
Indication
Hypertension
Assets addressing this indication.
Total attributable cost
$347.4B
$2,759/patient
Drug spend
$34.6B
$275/patient
10% of total cost is drugs
All severities (2017 ACC/AHA threshold) · US
Cardiovascular Disease / Hypertension
Indication
Assets addressing this indication.
Total attributable cost
$347.4B
$2,759/patient
Drug spend
$34.6B
$275/patient
10% of total cost is drugs
All severities (2017 ACC/AHA threshold) · US
73 of 73 assets